Shareholder Proposals to Broaden Access to Covid-19 Vaccines Rejected

Investors in three Covid-19 vaccine makers on Thursday rejected shareholder proposals aimed at broadening global access to the shots.

Pfizer Moderna and Johnson & Johnson had opposed the proposals, saying they already had taken steps to expand access to their vaccines in poorer countries.